Systems Oncology

1 follower

‌

Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance.

Industries

Biotechnology

Headquarters

Scottsdale, United States

Employees

11-50

Links

Org chart

Spyro Mousses

Co-Founder & Chief Executive Officer

Spyro Mousses

Collapse

Andrew Matricaria

CFO

Daniel D. Von Hoff

Co-Founder & Chief Clinical Strategist

Marvin O’Ketch

Associate Director, Immunobiology

David Lee

Lab Manager & Senior Scientist

Lizette Castano

Research Associate II

Robert G. Petit II

Drug Development Advisor

Katy Marhenke

Director, Business Development Operations

Teams

Leadership Team

3 members

Scientific Advisors

9 members

Research and Development

4 members

Similar companies

Elicio Therapeutics

1 follower

Artiva Biotherapeutics

1 follower

ByHeart

2 followers

Cytokinetics

11 followers

Capricor Therapeutics

1 follower

Neurocrine Biosciences

5 followers

Coherus BioSciences

5 followers

4D Molecular Therapeutics

3 followers

KIA

2 followers

The Cumulus Coffee Company

2 followers

Axsome Therapeutics

2 followers

Explore companies